How to ascertain drug safety in the context of benefit. Controversies and concerns.
Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KS, Silman AJ, Stevens R, Tyndall A.
J Rheumatol. 2009 Sep;36(9):2114-21.PMID: 19738223 [PubMed - indexed for MEDLINE]Related articles